U.S. Department of Health and Human Services
Indian Health Service: The Federal Health Program for American Indians and Alaska Natives
A - Z Index:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

Saturday, October 06, 2012

Division of Diabetes Treatment and Prevention - Leading the effort to treat and prevent diabetes in American Indians and Alaska Natives

HOME
ABOUT US
PROGRAMS
• SDPI
• Model Diabetes Programs
• IDEP
PEOPLE
• DDTP
• ADCs
• TLDC
LEARN Hubs
• CKD
• Foot Care
• Glucose Management
• Physical Activity
TRAINING
• Web-Based
• AADE Partnership
• External Trainings
• Conferences
RESOURCES
• Audit
• Client Education Materials
• Fact Sheets
• Ideas and Inspirations
• Online Catalog
• Other Resources
• Podcasts
• Printable Materials
(Instant Downloads)
• Provider Resources
TOOLS
• Best Practices
• Clinical Guidelines
• Curricula
• DM Treatment Algorithms
• Quick Guide Cards
SITE MAP

tools : quick guide cards : ckd : overview

Quick Guide Cards
Folder tab graphic with Overview, How To and Other Resources tabs
  • Algorithm Cards (1 of 2)

    • [PDF - 45KB / PDF - 229KB]

Why is this important?

3D rendering of kidneys

 

Important Resources

  • Quick Reference on UACR and eGFR Exit Disclaimer – You Are Leaving www.ihs.gov – Describes the two key markers for kidney disease, urine albumin and estimated glomerular filtration rate (eGFR).
  • Patient Education Videos Exit Disclaimer – You Are Leaving www.ihs.gov – Short videos demonstrating patient-provider interactions around common CKD questions. Topics include CKD and risk, treatment, testing and diagnosis, and dialysis and transplantation.
  • Early CKD detection/treatment decreases development of kidney failure 30-70%.
  • Screen, diagnose, monitor and treat CKD complications.
  • Early preparation for kidney replacement therapy (transplant, dialysis) improves outcomes.

Quick Facts

  • Screen all patients with type 2 diabetes yearly:
    • Creatinine/eGFR (estimated Glomerular Filtration Rate).
    • UACR (Urine Albumin to Creatinine Ratio).
  • Dx CKD: ≥3 mos duration of either:
    • decreased function - eGFR <60 mL/min/1.73 m2 or
    • evidence of damage - UACR ≥30 mg/g or other.
  • BG and BP control (ACE inhibitor/ARB) decreases CKD progression.
  • R/O potential causes of CKD not related to type 2 diabetes.
  • eGFR <60 mL/min/1.73 m2: monitor/treat CKD complications:
    • Acidosis
    • Anemia
    • CVD
    • Edema/fluid overload
    • Metabolic bone disease
    • Uremia
  • Monitor patients more closely if:
    • Amount of albuminuria is high (e.g., UACR >1000 mg/g) or
    • Rate of albuminuria increases rapidly.
    • Nephrology referral:
      • If unsure of cause of CKD (e.g., renal biopsy needed).
      • Difficulty controlling complications of CKD.
      • Usually once eGFR <30 mL/min/1.73 m2.
      • Rapid progression of CKD.
Overview How To Other Resources

Division of Diabetes Treatment and Prevention | Phone: (505) 248-4182 | Fax: (505) 248-4188 | diabetesprogram@ihs.gov